Common Stock, Shares Authorized of Can-Fite BioPharma Ltd. from Q4 2018 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Can-Fite BioPharma Ltd. quarterly Common Stock, Shares Authorized history and change rate from Q4 2018 to Q2 2025.
  • Can-Fite BioPharma Ltd. Common Stock, Shares Authorized for the quarter ending 30 Jun 2025 was 20B shares, a 300% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 20B +15B +300% 30 Jun 2025 6-K 28 Aug 2025
Q4 2024 10B +5B +100% 31 Dec 2024 6-K 28 Aug 2025
Q2 2024 5B 0 0% 30 Jun 2024 6-K 29 Aug 2024
Q4 2023 5B 0 0% 31 Dec 2023 20-F 14 Apr 2025
Q2 2023 5B 0 0% 30 Jun 2023 6-K 31 Aug 2023
Q4 2022 5B 0 0% 31 Dec 2022 20-F 28 Mar 2024
Q2 2022 5B 0 0% 30 Jun 2022 6-K 25 Aug 2022
Q4 2021 5B +4B +400% 31 Dec 2021 20-F 30 Mar 2023
Q2 2021 5B +4.5B +900% 30 Jun 2021 6-K 26 Aug 2021
Q4 2020 1B +500M +100% 31 Dec 2020 20-F 24 Mar 2022
Q2 2020 500M 30 Jun 2020 6-K 27 Aug 2020
Q4 2019 500M 0 0% 31 Dec 2019 20-F 25 Mar 2021
Q4 2018 500M 31 Dec 2018 6-K 01 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.